Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

79.08
BATS BZX Real-Time Price
As of 2:42pm ET
 -2.24 / -2.75%
Today’s Change
25.81
Today|||52-Week Range
99.45
+78.03%
Year-to-Date

Today’s Trading

Previous close81.32
Today’s open81.61
Day’s range77.95 - 81.61
Volume44,881
Average volume (3 months)1,833,736
Market cap$4.0B
Dividend yield--
Data as of 2:42pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)+7.35%
Earnings growth (this year)+17.12%
Earnings growth (next 5 years)-84.86%
Revenue growth (last year)--
P/E ratioNM
Price/Sales21,912.70
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...-0.13-0.26%
OPKOPKO Health Inc-0.06-0.88%
MNKMallinckrodt Plc-0.03-0.09%
PBYIPuma Biotechnology I...+0.85+0.68%
Data as of 2:44pm ET, 10/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$1.21
Annual revenue (last year)$78.0K
Annual profit (last year)-$349.1M
Net profit margin-447,611.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
Principal Financial Officer &
SVP-Finance
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts